Related Experiment Video
Updated: Mar 31, 2026

Detection of microRNA Expression in Peritoneal Membrane of Rats Using Quantitative Real-time PCR
Published on: June 27, 2017
microRNA regulation of peritoneal cavity homeostasis in peritoneal dialysis
Melisa Lopez-Anton1, Timothy Bowen1, Robert H Jenkins1
1Department of Nephrology, School of Medicine, College of Biomedical & Life Sciences, Cardiff University, Heath Park Campus, Cardiff CF14 4XN, UK.
Abstract:
Preservation of peritoneal cavity homeostasis and peritoneal membrane function is critical for long-term peritoneal dialysis (PD) treatment. Several microRNAs (miRNAs) have been implicated in the regulation of key molecular pathways driving peritoneal membrane alterations leading to PD failure. miRNAs regulate the expression of the majority of protein coding genes in the human genome, thereby affecting most biochemical pathways implicated in cellular homeostasis. In this review, we report published findings on miRNAs and PD therapy, with emphasis on evidence for changes in peritoneal miRNA expression during long-term PD treatment. Recent work indicates that PD effluent- (PDE-) derived cells change their miRNA expression throughout the course of PD therapy, contributing to the loss of peritoneal cavity homeostasis and peritoneal membrane function. Changes in miRNA expression profiles will alter regulation of key molecular pathways, with the potential to cause profound effects on peritoneal cavity homeostasis during PD treatment. However, research to date has mainly adopted a literature-based miRNA-candidate methodology drawing conclusions from modest numbers of patient-derived samples. Therefore, the study of miRNA expression during PD therapy remains a promising field of research to understand the mechanisms involved in basic peritoneal cell homeostasis and PD failure.
Insights
MicroRNAs (miRNAs) play a crucial role in maintaining peritoneal dialysis (PD) function. Changes in miRNA expression in PD effluent cells contribute to PD failure by disrupting peritoneal homeostasis.
Area of Science:
- Nephrology
- Molecular Biology
- Genetics
Background:
- Peritoneal dialysis (PD) relies on maintaining peritoneal cavity homeostasis and membrane function.
- MicroRNAs (miRNAs) are key regulators of gene expression and cellular pathways.
- Alterations in these pathways can lead to peritoneal membrane dysfunction and PD failure.
Purpose of the Study:
- To review current findings on the role of miRNAs in peritoneal dialysis (PD) therapy.
- To emphasize evidence of altered peritoneal miRNA expression during long-term PD.
- To highlight the impact of these changes on peritoneal cavity homeostasis and PD outcomes.
Main Methods:
- Literature-based review of published studies on miRNAs and PD.
- Analysis of evidence for changes in miRNA expression in peritoneal dialysis effluent (PDE)-derived cells.
- Emphasis on studies examining miRNA expression profiles during long-term PD treatment.
Main Results:
- PD effluent-derived cells exhibit altered miRNA expression during PD therapy.
- These miRNA expression changes contribute to the loss of peritoneal cavity homeostasis.
- Altered miRNA profiles impact key molecular pathways regulating peritoneal cell homeostasis.
Conclusions:
- Changes in miRNA expression are implicated in the progression of PD failure.
- Further research into miRNA expression during PD is essential for understanding peritoneal cell homeostasis.
- Investigating miRNA mechanisms offers a promising avenue for improving PD treatment and outcomes.
Related Concept Videos
Peritoneal Dialysis I: Introduction and Procedure
Peritoneal Dialysis III: Nursing Management
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications
Dialysis
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Dialysis
Acute Kidney Injury V: Interprofessional Care

